In addition to neurological symptoms, patients with ECHS1 mutations often display notable metabolic abnormalities, with elevated lactate and pyruvate levels in blood and cerebrospinal fluid, suggesting severe mitochondrial dysfunction—a hallmark of metabolic diseases [12, 13]. This evidence concerns the gene ECHS1 and metabolic disease.